Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Swedbank AB

Swedbank AB reduced its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 89.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 167,882 shares of the company's stock after selling 1,492,526 shares during the period. Swedbank AB owned approximately 0.09% of Doximity worth $7,315,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in DOCS. CANADA LIFE ASSURANCE Co lifted its position in Doximity by 22.7% during the first quarter. CANADA LIFE ASSURANCE Co now owns 80,464 shares of the company's stock valued at $2,165,000 after purchasing an additional 14,862 shares during the period. Price T Rowe Associates Inc. MD increased its position in Doximity by 0.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 559,826 shares of the company's stock worth $15,065,000 after purchasing an additional 2,190 shares during the last quarter. Janus Henderson Group PLC increased its holdings in shares of Doximity by 33.5% during the 1st quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company's stock worth $66,594,000 after buying an additional 621,590 shares during the last quarter. Jacobs Levy Equity Management Inc. acquired a new position in shares of Doximity in the 1st quarter valued at $8,541,000. Finally, Comerica Bank increased its position in shares of Doximity by 4.1% during the 1st quarter. Comerica Bank now owns 63,704 shares of the company's stock worth $1,714,000 after purchasing an additional 2,480 shares during the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have weighed in on DOCS. Morgan Stanley upgraded shares of Doximity from an "underweight" rating to an "equal weight" rating and lifted their price target for the company from $33.00 to $53.00 in a research report on Thursday, November 14th. KeyCorp upgraded shares of Doximity from a "sector weight" rating to an "overweight" rating and set a $70.00 price target on the stock in a research note on Friday, November 8th. Bank of America raised their price objective on shares of Doximity from $32.00 to $45.00 and gave the company a "neutral" rating in a research note on Monday, October 7th. The Goldman Sachs Group started coverage on shares of Doximity in a research note on Friday, November 15th. They set a "neutral" rating and a $58.00 target price on the stock. Finally, Baird R W raised shares of Doximity to a "strong-buy" rating in a research report on Tuesday, September 17th. Eleven research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $52.27.

Doximity Trading Down 0.3 %

Shares of Doximity stock traded down $0.15 during trading hours on Wednesday, hitting $53.39. 1,008,128 shares of the company were exchanged, compared to its average volume of 1,760,553. The business has a 50-day moving average of $44.83 and a 200-day moving average of $35.34. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $61.75. The stock has a market capitalization of $9.97 billion, a price-to-earnings ratio of 60.70, a P/E/G ratio of 3.91 and a beta of 1.30.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.